Fruquintinib plus best supportive care for patients with metastatic colorectal cancer: Characterization of patients who had an overall survival of ≥10 months in the FRESCO-2 study. Updated analysis of ...
The most common clinical tumor stages were T3 (48%), T2 (25%), and T4 or T4a (15%). Clinical node stage was ... neoadjuvant immune checkpoint inhibitors had shown positive results in dMMR colorectal ...
Keywords used for the search included “rectal cancer” “neoadjuvant immunotherapy” “PD ... of pCR and cCR warrants more future studies to solve the problem. Clinical T4 stage, N2 stage, and EMVI ...
Radiation dose intensification improves pathologic complete response rates in locally advanced rectal cancer but also leads ...
6don MSN
When we think of cancer, we often focus on the big symptoms, but colorectal cancer comes with side effects that don’t always ...
A qualitative study of surgeon-patient communication in the rectal cancer consultations,” published in the November 2024 ...
The American Cancer Society recently predicted there will be around 155,000 new cases of colorectal cancer and 52,900 deaths ...
Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.
Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback